Panacea Biotec Ltd.’s revenue in Q4FY23 rose 13% to ₹ 12,557 crores. Consolidated Profit After Tax came at ₹ 4,320 crores in Q4FY23 showcasing a 4% rise in profits on YoY basis. In this quarter’s results, the reports suggested that the firm has continued to deliver consistent performance in all key operational and financial indicators in Q4Y23.
Panacea Biotec Q4FY23; 8% Fall in Revenues
Tags: Biotechnology
Related Post
- Garden Reach Shipbuilders & Engineers Ltd Q2FY25; 10% rise in Profits
Garden Reach Shipbuilders & Engineers Ltd is a premier shipbuilding company in India under the…
-
GAIL (India) Ltd Q2FY25; 10% rise in Profits
Incorporated in 1984, GAIL, a Government of India undertaking, is an integrated natural gas company…
-
G R Infraprojects Ltd Q2FY25; 11% fall in Profits
Incorporated in the year 1995, G R Infraprojects Ltd is an integrated road Engineering, Procurement,…